Page last updated: 2024-08-23

bromocriptine and Heart Valve Diseases

bromocriptine has been researched along with Heart Valve Diseases in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (64.29)29.6817
2010's3 (21.43)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Clausen, MF; Fosbøl, E; Gislason, G; Kristensen, SL; Køber, L; Rørth, R; Torp-Pedersen, C; Weeke, PE; Westergaard, LM1
Arastu, MI; Curiale, AM; Lipton, BA; Longo, S; Nanda, S; Tessier, S1
Au, WL; Chan, YH; Lee, RK; Ng, KK; Tan, LC; Tan, NC1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C1
Andersohn, F; Garbe, E1
Martin, NM; Meeran, K; Tan, T1
Pullan, PT1
Azevedo, M; Boguszewski, CL; de Souza, AM; dos Santos, CM; Marini, LC; Sakamoto, KS1
Elenkova, A; Kalinov, K; Shabani, R; Zacharieva, S1
Bilge, A; Kurtulmus, N; Yarman, S1
Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P1
Chung, EJ; Kim, JY; Lee, WY; Park, SW1
Burger, E; Härtter, S; Kvernmo, T1

Reviews

1 review(s) available for bromocriptine and Heart Valve Diseases

ArticleYear
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
    Clinical therapeutics, 2006, Volume: 28, Issue:8

    Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine

2006

Other Studies

13 other study(ies) available for bromocriptine and Heart Valve Diseases

ArticleYear
Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine.
    BMC cardiovascular disorders, 2021, 12-28, Volume: 21, Issue:1

    Topics: Adult; Age Factors; Bromocriptine; Case-Control Studies; Comorbidity; Denmark; Dopamine Agonists; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Incidence; Registries; Risk Assessment; Risk Factors; Sex Factors; Time Factors

2021
Long-term low-dose cabergoline usage: Another association with cardiac valvulopathy.
    Echocardiography (Mount Kisco, N.Y.), 2023, Volume: 40, Issue:1

    Topics: Bromocriptine; Cabergoline; Ergolines; Heart Valve Diseases; Humans; Middle Aged; Pituitary Neoplasms

2023
Bromocriptine use and the risk of valvular heart disease.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3

    Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Heart Valve Diseases; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Receptor, Serotonin, 5-HT2B; Risk Factors; Severity of Illness Index; Tricuspid Valve Insufficiency

2009
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2

    Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors

2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States

2009
Dopamine agonists and hyperprolactinaemia.
    BMJ (Clinical research ed.), 2009, Mar-03, Volume: 338

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia

2009
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
    Internal medicine journal, 2009, Volume: 39, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography

2009
A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.
    Pituitary, 2012, Volume: 15, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Prolactinoma

2012
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.
    European journal of endocrinology, 2012, Volume: 167, Issue:1

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Prospective Studies

2012
Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas.
    Neuro endocrinology letters, 2012, Volume: 33, Issue:3

    Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Retrospective Studies; Risk Factors; Ultrasonography; Young Adult

2012
Cardiopulmonary complications of ergot-derivative dopamine agonists.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone

2004
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12

    Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide

2004
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Dopamine Agonists; Echocardiography; Ergot Alkaloids; Heart Valve Diseases; Humans; Middle Aged; Parkinson Disease; Pergolide; Reference Values

2006